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Effects of Pterostilbene on Activities and Protein Expression of Cytochrome P450 
1A1 (CYP1A1) and Glutathione S-Transferase (GST) in Benzo[a]pyrene-Induced 
HT-29 Colorectal Cancer Cell Line
(Kesan Pterostilbene terhadap Aktiviti dan Pengekspresan Protein Sitokrom P450 1A1 (CYP1A1) dan 
Glutation S-transferase (GST) Pada Sel Kanser Kolorektal HT-29 Teraruh Benzo[a]pirena)
AHMAD ROHI GHAzALI, WEE XIAn LEE, XIAnG YI CHEn, ASMARIAH AHMAD & TAvA SHELAn nAGAPAn
ABSTRACT
Drug Metabolizing Enzyme (DME) has been a target of natural chemopreventive agents to inhibit, retard and reverse the 
process of carcinogenesis. Pterostilbene, an analog to resveratrol has been reported to possess various pharmacological 
benefits including chemoprevention. In our study, benzo[a]pyrene-induced HT-29 colorectal cell line was used as the 
DME model. The activity of phase I enzyme CYP1A as determined by the 7-ethoxyresorufin O-deethylation (EROD) assay 
was found to be inhibited significantly by pterostilbene at 50 µM, 75 µM and 100 µM (p ≤ 0.01, p ≤ 0.05, p ≤ 0.01 
respectively) compared to the benzo[a]pyrene treated group. Meanwhile, pterostilbene induced glutathione-S-transferase 
(GST) activity significantly (p ≤ 0.01) at 50 µM as compared to the untreated. In addition, However, the protein expression 
of CYP1A1 and GST in pterostilbene treated group was not significantly affected compared to untreated. On the other 
hand, pterostilbene at 25 and 75 µM were able to increase the protein expression of transcription factor Nrf2 significantly 
(p ≤ 0.01). Results indicated that pterostilbene could reduce metabolic activation of procarcinogens and increase the 
detoxification process which can be potentially developed as chemopreventive agent.
Keywords: Pterostilbene; Cytochrome P450 1A1; Glutathione S-Transferase; Benzo[a]pyrene; HT-29 colorectal cell 
line
ABSTRAK
Enzim Metabolisma Dadah (EMD) telah menjadi sasaran agen kemopencegahan semulajadi untuk menghalang, merencat 
dan membalikkan proses karsinogenesis. Pterostilbene, analog kepada resveratrol telah dilaporkan mempunyai pelbagai 
manfaat farmakologi termasuk kemopencegahan. Dalam kajian kami, sel HT-29 teraruh benzo[a]pirena telah digunakan 
sebagai model EMD. Aktiviti enzim CYP1A fasa I ditentukan oleh asai 7-ethoxyresorufin O-deethylation (EROD) didapati 
merencat secara signifikan oleh pterostilbene pada kepekatan 50 μM, 75 μM dan 100 μM (p ≤ 0.01, p ≤ 0.05, p ≤ 0.01 
masing-masing) berbanding dengan kumpulan yang dirawat dengan benzo[a]pirena. Selain itu, pterostilbene juga 
mengaruh aktiviti glutation-S-transferase (GST) secara signifikan (p ≤ 0.01) pada kepekatan 50 μM berbanding dengan 
kumpulan yang tidak dirawat. Di samping itu, pengekspresan protein CYP1A1 dan GST dalam kumpulan yang dirawat 
pterostilbene tidak memberi kesan secara signifikan berbanding kumpulan tidak dirawat. Sebaliknya, pterostilbene pada 
kepekatan 25 μM dan 75 μM dapat meningkatkan pengekspresan protein faktor transkripsi Nrf2 secara signifikan (p ≤ 
0.01). Hasil kajian menunjukkan bahawa pterostilbene dapat mengurangkan pengaktifan metabolik prokarsinogen dan 
meningkatkan proses detoksifikasi yang berpotensi dapat dijadikan sebagai agen kemopencegahan.
Kata kunci: Pterostilbene; Sitokrom P450 1A1; Glutation S-Transferase; Benzo [a] pirena; sel kanser kolorektal HT-
29
InTRODUCTIOn
In year 2010, approximately 7.98 million people died of 
cancer alone, a 28 % increment from the past 2 decades 
(Lozano et al. 2012). Colorectal cancer is the third 
highest cause of death among men and the second highest 
among women around the world (Ferlay et al. 2013). 
Epidemiology study had shown that environmental factors, 
such as diet play an important role in the susceptibility 
of colon cancer (Martinez 2005), with 80% of colorectal 
cancer cases contributed by the dietary factor (Bingham 
2000). Polycyclic aromatic hydrocarbon, an environmental 
and dietary procarcinogen which can be found in barbequed 
meat has gained attention from researchers as it contributed 
toxicity to the gastrointestinal system. A study consisted of 
1008 subjects had shown an increase in the risk of rectal 
adenoma with the intake of benzo[a]pyrene, a polycyclic 
aromatic hydrocarbon in the meat (Ferrucci et al. 2012).
In the wake of curbing the increasing trend of cancer 
cases, chemoprevention had been the focus of many 
researches for the past few decades. Chemoprevention 
was defined as the use of natural or synthetic or biological 
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agent to inhibit, retard and reverse the multistep molecular 
process of carcinogenesis (Sporn 1976). Phytochemicals 
could be a chemoprevention agent due to its nature to 
disrupt the process of carcinogenesis. According to Surh 
(2003), some phytochemicals could act as a cancer blocking 
agent or cancer suppressing agent. Phytochemicals, 
such as pterostilbene has also gained much attention in 
the field of cancer research due to its numerous health 
benefits (McCormack & McFadden 2012). Pterostilbene 
(trans-3,5-dimethoxy-4’-hydroxystilbene) is a natural 
dimetylether analog of resveratrol that can be found 
in grapes and blueberries (Rimando et al. 2004). The 
presence of methoxyl functional groups in the phenolic 
ring increases its oral absorption and bioavailability 
which is greater than resveratrol. (Kapetanovic et al. 
2011). Moreover, pterostilbene possess 7 times longer 
half-life than resveratrol (Remsberg et al. 2008). Due 
to its pharmacological benefits, pterostilbene is more 
favoured in the chemoprevention research compared to 
resveratrol. In vivo studies had also demonstrated the 
ability of pterostilbene in killing cancer cells, slowing the 
growth of cancer cells and inhibiting the initiation process 
of normal cells into precancerous cell under electrophilic 
stress (Schneider et al. 2010).
There are various mechanisms in chemoprevention 
that have been elucidated. In this present study, we mainly 
focused on the modulation of Drug Metabolizing Enzymes 
(DME), mainly phase I and II enzymes that involve in the 
detoxification of xenobiotics. Phase I DME, mainly the 
cytochrome P450 metabolic activates procarcinogens, such 
as benzo[a]pyrene to genotoxic electrophilic intermediates 
which can lead to cancer. Cytochrome P450 1A1 (CYP1A1) 
and its isoforms, CYP1A2 and CYP1B1 are able to 
metabolically activate procarcinogen benzo[a]pyrene into 
oxide and diol forms which can bind to DnA molecules 
and form DnA adduct, leading to the initiation of cancer 
(Ioannides & Lewis 2004). Phase II DME which consist 
of glutathione S-transferase (GST) and nAD(P)H:quinone 
oxidoreductase 1 (nQO1) help the process of conjugation 
of the electrophilic metabolites to a more water soluble 
derivative, which completes the cycle of detoxification 
(Guo et al. 2010). GST is the enzyme responsible for the 
cellular protection against the attack of reactive metabolites 
by conjugating the metabolites with glutathione (Sheweita 
& Tilmisany 2003). Regulation, expression and gene 
coding activities of phase I and II DME are the important 
factors in determining the propensity towards cancer 
(nebert et al. 1996). The objective of chemoprevention 
can be achieved via the inhibition of metabolic activation 
of procarcinogen to ultimate carcinogen, at the same time, 
inducing the activity of phase II detoxification enzymes 
(Wattenberg 1996). Furthermore, cellular defences against 
chemical insults, whether of endogenous or exogenous 
origins, are regulated by transcription factor nuclear factor 
erythroid 2-related factor 2 (nrf2) which regulates the 
gene expression of phase II enzymes via the interaction 
with Antioxidant Response Element (ARE) (Yu & Kensler 
2005).
The objective of our study was to determine the effect 
of pterostilbene on the activities and proteins expression 
of phase I and II DME namely CYP1A1 and GST under the 
induction of benzo[a]pyrene. To give a better picture on 
the induction mechanism of phase II enzymes, the effect 
of pterostilbene on the protein expression of transcription 
factor nrf2 was also investigated.
MATERIALS AnD METHODS
MATERIALS
Human colorectal carcinoma cell line HT-29 was obtained 
from ATCC (Rockville, MD USA). Chemicals used for 
treatment were pterostilbene (C6H16O3), benzo[a]pyrene and 
resveratrol which were purchased from EMD Biosciences/
Calbiochem® (USA). Chemicals for EROD assays composed 
of 7-ethoxyresorufin, resorufin, dicumarol, sodium asetate, 
β-glucuronidase/arylsulfatase and methanol together 
with chemicals for GST assay which were 1-chloro-2,4,-
dinitrobenzene (CDnB), reduced L-glutathione (GSH) 
and (5,5-dithio-bis-(2-nitrobenzoic acid) (DTnB) were 
purchased from Sigma-Aldrich (USA).
CELL CULTURE
HT-29 cells were grown in modified McCoy’s 5A media 
supplemented with 10% (v/v) fetal bovine serum and 1% 
(v/v) penicillin/streptomycin in a humidified atmosphere 
of 5% CO2 at 37°C.
CELL TREATMEnT
The cells were incubated with pterostilbene at the 
concentrations of 25, 50, 75 and 100 µM and resveratrol 
at the concentration at 100 µM for 24 hours. After the 24 
hours incubation, the cells were then induced with 10 µM 
benzo[a]pyrene (BaP) and incubated for 24 hours prior to 
harvesting. As for untreated control, the cells were cultured 
in the absence of pterostilbene for 24 hours followed by 10 
µM BaP treatment for 24 hours prior to harvesting.
7-ETHOXYRESORUFIn O-DEETHYLATIOn (EROD) ASSAY
EROD assay was done to determine the activity of 
7-ethoxyresorufin O-deethylation by CYP1A1 enzymes. 
The assay was done according to the method by Mingoia 
et al. (2007) with some modifications. The standard curve 
was first done with the 0-200 pmol resorufin. Briefly, the 
culture media with the treatments was removed and gently 
washed with PBS. Then, the cells were incubated with 
100 µl PBS containing 8 µM 7-etoxyresorufin and 10 μM 
dicumarol. The plates were then gently shaken to ensure 
even mixing followed by incubating in 37°C and 5% CO2 
incubator. After incubation, about 75 µl PBS in the wells 
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were aliquoted to black-coloured 96-well microtiter plate. 
About 10 µl 0.5 M sodium acetate was pipetted into each 
well before adding 15 μl β-glucuronidase/arylsulfatase 
which had been diluted with distilled water at 1:100 ratio 
(v/v). The plate was shaken gently before incubating for 
2 hours at 37°C. The reaction of the enzyme was stopped 
by adding 100 µl methanol in each well. Then, about 100 
µl of the mixture was then discarded and about 100 µl 0.5 
M glycine-sodium hydroxide was pipetted into each well. 
Finally, the concentration of resorufin was determined 
using spectrofluorometer at the excitation wavelength 
of 530 nm and emission wavelength of 590 nm. The 
EROD activity was calculated with the formula below and 
expressed in pmol/min/105 cell.
GLUTATHIOnE S-TRAnSFERASES (GST) ASSAY
The GST activity in the samples was determined using 
GST assay (Habig and Jakoby 1981) which based on 
the rate of glutathione conjugation of 1-chloro-2,4,-
dinitrobenzene (CDnB) as substrate to form product of 
S-(2,4-dinitrophenyl)-glutathione (GS-DNB). Then, 840 μl 
phosphate buffer (100 mM K2HPO4 and 100 mM KH2PO4) 
pH 6.5 was used as blank. 100 μl GSH (1 mM) and 50 μl of 
the sample were pipetted into a 1 ml cuvette along with 840 
μl phosphate buffer. 10 μl CDnB (75 mM) was then added 
into the reaction mixture to start mixing and the mixture 
was mixed immediately. The rate of reaction (abs/min) was 
read using Uv spectrophotometer at 340 nm wave length for 
five minutes. The protein concentration of the samples was 
determined using Bradford assay (1976). The extinction 
coefficient of 9.6 mM-1cm-1 was used to calculate the GST 
activity of the samples.
WESTERn BLOT AnALYSIS OF CYP1A1, GST AnD nRF2
Firstly, After determining the protein concentration in the 
samples were determined using Bradford assay. Then, the 
protein samples and protein standard were subjected to 
SDS-polyacrylamide gel electrophoresis (stacking gel, 
5% w/v acrylamide; separation gel, 12% w/v acrylamide) 
and transferred to PvDF membrane by using Bio-Rad Mini 
Transblot Module. The Western blots were subsequently 
blocked with blocking solution and incubated overnight 
with the primary antibodies such as CYP1A1 and GST 
which were diluted with 1: 1000 ratio with 5% skimmed 
milk. The blots were washed and incubated with secondary 
antibodies for 2 hours. Quantitative densitometric 
evaluation of protein bands was performed using a gel 
documentation Fusion FX which employed software 
FusionCapt Advance FX7, Fusion Ink. The blots were then 
washed and incubated with primary beta-actin mouse mAb, 
washed and then incubated with the secondary anti-mouse 
IgG, with both antibodies diluted in the ratio of 1:10,000 
with 5% skimmed milk. The blots were then quantified 
using similar instrumentation as described as above.
STATISTICAL AnALYSIS
Data were analysed using GraphPad Prism version 6.0 
software (GraphPad Software, Inc. California, USA) and 
were presented as mean ± S.E.M of the triplicate study. 
One-Way AnOvA was used to compare the treatment group 
with control. The comparison was deemed statistically 
significant when p ≤ 0.05.
RESULTS AnD DISCUSSIOn
The effects of pterostilbene on the activity and protein 
expression of by CYP1A1 in benzo[a]pyrene-induced 
HT-29 cells.
As shown in both Figure 1 and Figure 2, benzo[a]
pyrene at 10 µM was able to increase the EROD activity 
and protein expression of CYP1A1 significantly compared 
to negative control. While significant inhibitory effect on 
EROD activity could be observed in the cells treated with 
pterostilbene at the concentration of 50, 75 and 100 µM 
(Figure 1) comparably to the BaP control, pterostilbene 
was not able to inhibit the expression of CYP1A1 enzyme 
significantly at all concentration tested. 
BaP: Benzo[a]pyrene; R: Resveratrol; P: Pterostilbene
FIGURE 1. EROD activity by CYP1A1 enzymes in benzo[a]pyrene-induced HT-29 cells of various experimental groups. Each value 
was represented by mean ± S.E.M. (n = 3)
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Benzo[a]pyrene can activate the gene transcription 
of CYP1A1 via the binding of benzo[a]pyrene with aryl 
hydrocarbon receptor nuclear translocator (ARnT) with the 
translocation of aryl hydrocarbon receptor (AhR) (Whitlock 
1999). Our results were in agreement with Ciolino and Yeh, 
(1999) where they showed resveratrol had the ability to 
inhibit carcinogen activity by CYP1A1/1A2 enzymes in 
HepG2 cells competitively. As for pterostilbene, our results 
on pterostilbene treatment were in agreement with Ghazali 
et al., (2012) and Mikstacka et al., (2007). However, 
pterostilbene was not able to inhibit the protein expression 
of CYP1A1 significantly. Due to the short half-life of 
CYP1A1 mRnA, instability in translation and protein 
expression of CYP1A1 might occur (Lekas et al. 2000). 
nevertheless, the inhibitory ability of pterostilbene on 
EROD activity suggested that pterostilbene can be a potential 
chemopreventive agent with the inhibiton of metabolic 
activation of procarcinogen, such as benzo[a]pyrene. 
THE EFFECTS OF PTEROSTILBEnE On THE ACTIvITY 
AnD PROTEIn EXPRESSIOn OF GST In BEnzO[A]PYREnE-
InDUCED HT-29 CELLS
As shown in Figure 3, pterostilbene at all concentrations 
were able to increase the activity of GST, with significant 
effects observed in the cells treated with 50 µM pterostilbene 
compared to the negative control The protein expression 
of GST was presented in Figure 4. Both resveratrol and 
pterostilbene did not show any significant effect on the 
protein expression of GST.
BaP: Benzo[a]pyrene; R: Resveratrol; P: Pterostilbene
FIGURE 3. GST activity in benzo[a]pyrene-induced HT-29 cell of various experimental groups. Each value was represented by 
triplicate mean ± S.E.M. (n = 3)
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FIGURE 2. Protein expressions of CYP1A1 enyzme in benzo[a]pyrene-induced HT-29 cell of various experimental groups for 24 
hours. Each value was represented by triplicate mean ± S.E.M. (n = 3)
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FIGURE 4. Protein expresson of GST enyzme in benzo[a]pyrene-induced HT-29 cells of various experimentals groups for 24 hours. 
Each value was represented by mean ± S.E.M. (n = 3)
Our results were comparable to study by Ghazali et 
al. (2012) which showed an increase in GST activity after 
pterostilbene treatment. However, the increment was 
reduced with concentration of pterostilbene, This might 
be due to the cytotoxic effect exerted by pterostilbene at 
high concentration, as MTT assay demonstrated only 70 % 
cell viability was registered at 100 µM pterostilbene. Even 
though pterostilbene was not able to increase the protein 
expression of GST significantly, its ability to induce GST 
activity proved that the potential of pterostilbene to increase 
glutathione conjugation of electrophilic xenobiotics for 
detoxification, reducing the risk of carcinogenic initiation 
process.
THE EFFECTS OF PTEROSTILBEnE On THE PROTEIn 
EXPRESSIOn OF nRF2 In BEnzO[A]PYREnE-InDUCED HT-29 
CELLS
Figure 5 showed that pterostilbene at all concentrations 
were able to increase the protein expression of transcription 
factor nrf2 in benzo[a]pyrene-induced HT29 cells 
compared to negative control, with a significant increment 
at 25 µM and 75 µM pterostilbene treated group. 
nuclear factor erythroid 2-related factor 2 (nrf2) 
plays an important role in preventing xenobiotic-induced 
toxicity and carcinogen-related tumorigenesis. The cellular 
protection effect is mainly due to the induction of phase 
II drug metabolizing enzymes or antioxidant enzymes via 
nrf2-antioxidant response element (ARE) pathway (Shen 
and Kong, 2009). Our study depicted that pterostilbene was 
better in inducing nrf2 compared to resveratrol. Results on 
pterostilbene treatment group were supported by Chiou et 
al. (2011) where it showed that the induction of nrf2 was 
greater by pterostilbene compared to resveratrol in a colon 
carcinogenesis rat model.
With the induction of transcription factor nrf2, the 
expression of protein expression of phase II enzymes such 
as nAD(P)H:quinone oxidoreductase 1 (nQOI), glutamate 
cysteine ligase (GCL) and UDP-glucuronosyltransferase 
(UGT) will be increased. nrf2 also regulates the gene 
expression of antioxidant protein, anti-inflammation 
protein, calcium homeostasis protein and signalling 
molecules (Lee et al. 2003). Our study suggested that 
pterostilbene could protect cells from the oxidative stress, 
inflammation, and environmental pollutant-induced cancer 
via a complex detoxification system which would involve 
the transcription factor nrf2.
COnCLUSIOn
Our study showed the potential role of pterostilbene in 
inhibiting EROD activity by CYP1A1 and increase GST 
activity in benzo[a]pyrene-induced HT-29 cells. Besides, 
pterostilbene can increased the protein expression of nrf2. 
In conclusion, pterostilbene is a potential chemoprevention 
agent through modulation of phase I and II drug 
metabolizing enzymes’ activities and enhancement of the 
protein expression of nrf2.
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BaP: Benzo[a]pyrene; R: Resveratrol; P: Pterostilbene
FIGURE 5. Protein expression of transcription factor nrf2 in benzo[a]pyrene-induced HT-29 cells treated with pterostilbene for 24 
hours. Each value was represented by triplicate mean ± S.E.M. (n = 3)
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